Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization
Authors:
- Gordon D. WuGWGordon D. Wu
- Yao HeYHYao He
- Ning-Ning ChaiNCNing-Ning Chai
- Mieko ToyodaMTMieko Toyoda
- Robert DunnRDRobert Dunn
- Marilyn R. KehryMKMarilyn R. Kehry
- Andrew S. KleinAKAndrew S. Klein
- Stanley C. JordanSJStanley C. Jordan
- 1 July 2008
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 19 (3-4) , 178-186
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Analysis of HLA Class I Specific Antibodies in Patients with Failed AllograftsTransplantation, 2007
- Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulinClinical Transplantation, 2006
- ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report.Xenotransplantation, 2006
- First two ABO‐incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the BalkansXenotransplantation, 2006
- Immunoglobulin M-to-Immunoglobulin G Anti-Human Leukocyte Antigen Class II Antibody Switching in Cardiac Transplant Recipients Is Associated With an Increased Risk of Cellular Rejection and Coronary Artery DiseaseCirculation, 2005
- HLA Antibody Identification With Single Antigen Beads Compared To Conventional MethodsHuman Immunology, 2005
- Current approaches to treatment of antibody‐mediated rejectionPediatric Transplantation, 2005
- Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeysTransplant Immunology, 2003
- Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresisTransplantation, 2002
- Hapten-Induced Primary and Memory Humoral Responses Are Inhibited by the Infusion of Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab)Clinical Immunology, 2001